Chemical Formula: C15H19N5O

Chemical Formula C15H19N5O

Found 5 metabolite its formula value is C15H19N5O

2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-

2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-

C15H19N5O (285.159)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C308 - Immunotherapeutic Agent

   

N-Monodesmethyl-rizatriptan

3-[2-(dimethylamino)ethyl]-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-6-ol

C15H19N5O (285.159)


N-Monodesmethyl-rizatriptan is a metabolite of rizatriptan. Rizatriptan (Maxalt) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT). Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan. Rizatriptan is available only by prescription in Australia, the United States, Canada and New Zealand. (Wikipedia)

   

2-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]acetamide

2-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]acetamide

C15H19N5O (285.159)


   

6-Hydroxyrizatriptan

6-Hydroxyrizatriptan

C15H19N5O (285.159)


   

N-Propionyl-N-(4,6,7-trimethyl-quinazolin-2-yl)-guanidine

N-Propionyl-N-(4,6,7-trimethyl-quinazolin-2-yl)-guanidine

C15H19N5O (285.159)